Breath Analysis for Lung Cancer Early Detection—A Clinical Study
Metabolites · 12.12.2023 · 13 (12) · 1197
DOI: 10.3390/metabo13121197 ↗Kurz gefasst
Fachartikel in der Zeitschrift Metabolites, online erschienen am 12.12.2023. Verfasst von Zhunan Jia und 3 weiteren Autor:innen. Beteiligte Einrichtung: NUSNNI-Nanocore, National University of Singapore, Singapore 117411, Singapore. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This clinical study presents a comprehensive investigation into the utility of breath analysis as a non-invasive method for the early detection of lung cancer. The study enrolled 14 lung cancer patients, 14 non-lung cancer controls with diverse medical conditions, and 3 tuberculosis (TB) patients for biomarker discovery. Matching criteria including age, gender, smoking history, and comorbidities were strictly followed to ensure reliable comparisons. A systematic breath sampling protocol utilizing a BIO-VOC sampler was employed, followed by VOC analysis using Thermal Desorption–Gas Chromatography–Mass Spectrometry (TD-GC/MS). The resulting VOC profiles were subjected to stringent statistical analysis, including Orthogonal Projections to Latent Structures—Discriminant Analysis (OPLS-DA), Kruskal–Wallis test, and Receiver Operating Characteristic (ROC) analysis. Notably, 13 VOCs exhibited statistically significant differences between lung cancer patients and controls. The combination of eight VOCs (hexanal, heptanal, octanal, benzaldehyde, undecane, phenylacetaldehyde, decanal, and benzoic acid) demonstrated substantial discriminatory power with an area under the curve (AUC) of 0.85, a sensitivity of 82%, and a specificity of 76% in the discovery set. Validation in an independent cohort yielded an AUC of 0.78, a sensitivity of 78%, and a specificity of 64%. Further analysis revealed that elevated aldehyde levels in lung cancer patients’ breath could be attributed to overactivated Alcohol Dehydrogenase (ADH) pathways in cancerous tissues. Addressing methodological challenges, this study employed a matching of physiological and pathological confounders, controlled room air samples, and standardized breath sampling techniques. Despite the limitations, this study’s findings emphasize the potential of breath analysis as a diagnostic tool for lung cancer and suggest its utility in differentiating tuberculosis from lung cancer. However, further research and validation are warranted for the translation of these findings into clinical practice.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- NUSNNI-Nanocore, National University of Singapore, Singapore 117411, Singapore.
- Center for Quantum Research and Technology, Homer L. Dodge Department of Physics and Astronomy, University of Oklahoma, Norman, OK 73019, USA.
- Respiratory and Critical Care Medicine, National University Hospital, 1E Kent Ridge Road, Singapore 119228, Singapore.
ORCID-Profile: Velmurugan Thavasi
Zitieren
APA
Jia, Z., Thavasi, V., Venkatesan, T., & Lee, P. (2023). Breath Analysis for Lung Cancer Early Detection—A Clinical Study. Metabolites, 13(12), 1197. https://doi.org/10.3390/metabo13121197
Vancouver
Jia Z, Thavasi V, Venkatesan T, Lee P. Breath Analysis for Lung Cancer Early Detection—A Clinical Study. Metabolites. 2023;13(12):1197. doi:10.3390/metabo13121197
BibTeX
@article{Jia2023,
author = {Jia, Zhunan and Thavasi, Velmurugan and Venkatesan, Thirumalai and Lee, Pyng},
title = {Breath Analysis for Lung Cancer Early Detection—A Clinical Study},
journal = {Metabolites},
year = {2023},
volume = {13},
number = {12},
pages = {1197},
doi = {10.3390/metabo13121197}
}
EUVIMED